Clinical Trials Directory

Trials / Sponsors / Noxopharm Limited

Noxopharm Limited

Industry · 7 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingClinical Trial to Evaluate Safety, Tolerability, and Pharmacokinetics of SOF-SKN in Healthy Participants
Cutaneous Lupus Erythematosus
EARLY_Phase 12025-07-14
TerminatedA Study of NOX66 Plus Doxorubicin in Anthracycline-naïve, Adult Patients With Soft Tissue Sarcoma
Metastatic Soft-tissue Sarcoma
Phase 12022-02-11
TerminatedA Study of NOX66 and External Beam Radiotherapy in Patients With Metastatic Castration-resistant Prostate Canc
Metastatic Castration-resistant Prostate Cancer and Other Solid Tumors
Phase 1 / Phase 22021-10-25
CompletedA Dose Escalation and Dose Expansion Study of NOX66 in the Treatment of COVID-19
Covid19
Phase 12020-09-30
WithdrawnA Study of Safety and Tolerability of NOX66 in Healthy Volunteers
Healthy Volunteers
Phase 12019-03-01
CompletedSafety and Tolerability of NOX66 in Combination With Palliative Radiotherapy in Patients With Late-Stage Prost
Cancer
Phase 12017-11-01
CompletedSafety, PK and Efficacy of NOX66 as a Monotherapy and Combined With Carboplatin in Refractory Solid Tumours
Cancer
Phase 1 / Phase 22017-03-03